However, PD-L1 exerts immunosuppressive effects through engagement of its receptor PD-1 on immune cells, triggering T lymphocyte apoptosis, functional anergy, and terminal exhaustion—thereby enabling immune evasion of PD-L1-expressing tumor cells from CD8+ cytotoxic T lymphocyte-mediated killing10,11. The gene discussed is CD274; the disease is neoplasm.